COVID-19 vaccine: Here’s how much ‘Covishield’ and ‘Covaxin’ will cost

The Drug Controller General of India (DCGI) Dr. VG Somani has approved the ‘Covishield’ by Serum Institute of India and ‘Covaxin’ by Bharat Biotech for emergency use of India on January 3, 2021. The vaccines will roll out in the coming weeks in India.

The ‘Covishield’ and ‘Covaxin’ were approved for emergency use after the meeting of a Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) held on January 1, 2021. ‘Covishield’ was approved for emergency use on January 1, while the ‘Covaxin’ was approved for restricted use on January 2, 2021. 

Adar Poonawalla, CEO of Serum Institute of India, has disclosed the prices of ‘Covishield’. There are two different prices that have been fixed for the ‘Covishield’ vaccine.‘Covishield’ will be sold to the government at INR 250 and to the private markets at INR 1000. The company which is based in Pune is producing 50 to 60 million doses of the ‘Covishield’ each month said Poonawalla. He also stated that by mid-2021, the government aims to vaccinate more than 130 crore people.

In an interview with Zee News, Poonawalla said: “We are ready to provide the vaccine for the government. We have sent our proposal and are waiting for the contract to be signed with the government. The vaccine will be made available to the government within 10 days of the contract.”

However, the Serum Institute of India is yet to receive permission from the government to export ‘Covishield’ and aims to export the vaccine in more than 50 countries of the world. Poonawalla further said, “We have bilateral relations with Saudi Arabia and some other countries. We have sought permission from the government in this regard. After getting this approval, we will be able to deliver our medicine to more than 50 countries of the world”.

Prime Minister Narendra Modi congratulated all the hardworking scientists and innovators upon the approval of the ‘Covishield’ and the ‘Covaxin’ by the DCGI stating that the country is moving towards a healthier and a “COVID-free” nation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Signal app experiences issues globally due to huge user influx

Signal, the popular instant messaging application, appears to be down due to the sudden influx of people joining the Signal app. Signal has been...

Xiaomi Mi 11 global version spotted on FCC listing ahead of official launch in February

Xiaomi Mi 11 was launched in China last month, becoming the world’s first smartphone to be powered by Qualcomm Snapdragon 888 5G SoC. Xiaomi...

Lenovo’s ThinkReality AR glasses to project virtual desktops into your eyes

ThinkReality A3 has the ability to superimpose virtual graphics over real world views, but for that, it needs a tethered PC connection or...

Related Articles

Razer unveils futuristic Project Brooklyn gaming chair at CES 2021

At the Consumer Electronic Show 2021 (CES 2021), Razer unveiled a number of innovative, AI-based products and Project Brooklyn is one of them. Project...

YouTube tests new feature to let users purchase products shown in videos

YouTube, one of the most popular video streaming platforms, is reportedly testing a new feature that will allow its users to buy the products...

Signal app experiences issues globally due to huge user influx

Signal, the popular instant messaging application, appears to be down due to the sudden influx of people joining the Signal app. Signal has been...